The
increasing prevalence of cardiovascular diseases, liver lesions, renal lesions,
gastrointestinal diseases, and vascular diseases globally is anticipated to
boost the market growth, as these are major areas of clinical application of
Contrast-enhanced Ultrasound (CEUS) systems.
The
presence of several potential benefits in CEUS such as being completely
radiation-free, quick, cost-efficient, and patient-friendly, in comparison to
the contrast-enhanced CT/MRI, is expected to propel the growth of the market.
Increasing
approvals of CEUS by regulatory bodies for new indications are expected to
propel the growth of the market during the forecast period. For instance, the
ultrasound dyes which were originally indicated for cardiac imaging have
received an extension of indication for pediatric and liver imaging in several
countries.
Request a
free sample copy or view report summary: Contrast
Enhanced Ultrasound Market Report
Contrast Enhanced Ultrasound Market Report Highlights
- Based on
product, the equipment segment held the largest revenue share in 2019.
This can be attributed to the largest installed base of sonography
technology compatible with CEUS
- The contrast
agents segment is expected to grow at the fastest rate of 4.0% during
the forecast period owing to its approval of usage in the liver
and pediatric imaging by the FDA
- Based on
type, the non-targeted segment held the largest revenue share in 2019 as
most of the commercially available dyes are non-targeted agents
- Numerous
clinical trials conducted to determine the potential of diagnostic and
therapeutic application of targeted imaging dyes in cancer care are
expected to drive the segment during the forecast period
- The
hospitals segment held the largest market share in 2019 owing to the
increasing number of emergency visits with medical conditions such as
abdominal pain, abdominal/thoracic trauma, and cardiac complications
- The clinics
segment is anticipated to witness lucrative growth over the forecast
period owing to the realization of economic and patient care benefits with
the adoption of sonography devices in practice among physicians at primary
and secondary care
- In Asia
Pacific, the market is expected to grow at the fastest rate owing to the
limited accessibility to advanced CT/MRI imaging modalities such as CT and
MRI, and the growing burden of cardiovascular disorders in China and
India.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment